# A Dose-finding Study of ASP4070

> **NCT03101267** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 150 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal

## Interventions

- **DRUG:** ASP4070
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03101267
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-13
- **Primary completion:** 2018-01-26
- **Final completion:** 2018-10-27
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-11-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03101267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03101267, "A Dose-finding Study of ASP4070". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03101267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*